Gaucher Disease Drugs Market Size, Share & Trends Report

Gaucher Disease Drugs Market Size, Share & Trends Analysis Report By Type (Type 1, Type 2, Type 3, Others) By Therapy (Enzyme Replacement Therapy, Substrate Replacement Therapy, Others), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-599-1
  • Number of Pages: 84
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Contents

Chapter 1. Methodology and Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Type
                       1.1.2. Therapy
                       1.1.3. Regional scope
                       1.1.4. Estimates and forecast timeline
                   1.2. Research Methodology
                   1.3. Information Procurement
                       1.3.1. Purchased database
                       1.3.2. GVR’s internal database
                       1.3.3. Secondary sources
                       1.3.4. Primary research
                       1.3.5. Details of primary research
                   1.4. Information or Data Analysis
                   1.5. Market Formulation & Validation
                   1.6. Model Details
                   1.7. List of Secondary Sources
                   1.8. List of Primary Sources
                   1.9. Objectives
Chapter 2. Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                       2.2.1. Type outlook
                       2.2.2. Therapy outlook
                       2.2.3. Regional outlook
                   2.3. Competitive Insights
Chapter 3. Gaucher Disease Drugs Market Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent market outlook
                       3.1.2. Related/ancillary market outlook
                   3.2. Penetration & Growth Prospect Mapping
                   3.3. Market Dynamics
                       3.3.1. Market driver analysis
                       3.3.2. Market restraint analysis
                   3.4. Gaucher Disease Drugs Market Analysis Tools
                       3.4.1. Industry Analysis - Porter’s
                           3.4.1.1. Supplier power
                           3.4.1.2. Buyer power
                           3.4.1.3. Substitution threat
                           3.4.1.4. Threat of new entrant
                           3.4.1.5. Competitive rivalry
                       3.4.2. PESTEL Analysis
                           3.4.2.1. Political landscape
                           3.4.2.2. Technological landscape
                           3.4.2.3. Economic landscape
Chapter 4. Gaucher Disease Drugs: Type Estimates & Trend Analysis
                   4.1. Gaucher Disease Drugs Market: Key Takeaways
                   4.2. Gaucher Disease Drugs Market: Movement & Market Share Analysis, 2022 & 2030
                   4.3. Type 1
                       4.3.1. Type 1 market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.4. Type 2
                       4.4.1. Type 2 market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.5. Type 3
                       4.5.1. Type 3 market estimates and forecasts, 2018 to 2030 (USD Million)
                   4.6. Others
                       4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Gaucher Disease Drugs: Therapy Estimates & Trend Analysis
                   5.1. Gaucher Disease Drugs Market: Key Takeaways
                   5.2. Gaucher Disease Drugs Market: Movement & Market Share Analysis, 2022 & 2030
                   5.3. Enzyme Replacement Therapy
                       5.3.1. Enzyme replacement therapy market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.4. Substrate Replacement Therapy
                       5.4.1. Substrate replacement therapy market estimates and forecasts, 2018 to 2030 (USD Million)
                   5.5. Others
                       5.5.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Gaucher Disease Drugs Market: Regional Estimates & Trend Analysis
                   6.1. Regional Outlook
                   6.2. Gaucher Disease Drugs Market by Region: Key Marketplace Takeaway
                   6.3. North America
                       6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.2. U.S.
                           6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.3.3. Canada
                           6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.4. Europe
                       6.4.1. UK
                           6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.2. Germany
                           6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.3. France
                           6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.4. Italy
                           6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.5. Spain
                           6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.6. Sweden
                           6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.7. Norway
                           6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.4.8. Denmark
                           6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.5. Asia Pacific
                       6.5.1. Japan
                           6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.2. China
                           6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.3. India
                           6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.4. Australia
                           6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.5. Thailand
                           6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.5.6. South Korea
                           6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.6. Latin America
                       6.6.1. Brazil
                           6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.6.2. Mexico
                           6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.6.3. Argentina
                           6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                   6.7. MEA
                       6.7.1. Saudi Arabia
                           6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.2. South Africa
                           6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.3. UAE
                           6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
                       6.7.4. Kuwait
                           6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
                   7.1. Recent Developments & Impact Analysis, By Key Market Participants
                   7.2. Market Participant Categorization
                       7.2.1. Sanofi
                           7.2.1.1. Company overview
                           7.2.1.2. Financial performance
                           7.2.1.3. Product benchmarking
                           7.2.1.4. Strategic initiatives
                       7.2.2. Takeda Pharmaceutical Company Limited
                           7.2.2.1. Company overview
                           7.2.2.2. Financial performance
                           7.2.2.3. Product benchmarking
                           7.2.2.4. Strategic initiatives
                       7.2.3. Pfizer Inc
                           7.2.3.1. Company overview
                           7.2.3.2. Financial performance
                           7.2.3.3. Product benchmarking
                           7.2.3.4. Strategic initiatives
                       7.2.4. Johnson & Johnson Services, Inc.
                           7.2.4.1. Company overview
                           7.2.4.2. Financial performance
                           7.2.4.3. Product benchmarking
                           7.2.4.4. Strategic initiatives
                       7.2.5. ERAD Therapeutic
                           7.2.5.1. Company overview
                           7.2.5.2. Financial performance
                           7.2.5.3. Product benchmarking
                           7.2.5.4. Strategic initiatives


List of Tables

Table 1 List of abbreviation
Table 2 North America Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 3 North America Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 4 North America Gaucher disease drugs market, by region, 2018 - 2030 (USD Million)
Table 5 U.S. Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 6 U.S. Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 7 Canada Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 8 Canada Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 9 Europe Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 10 Europe Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 11 Europe Gaucher disease drugs market, by region, 2018 - 2030 (USD Million)
Table 12 UK Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 13 UK Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 14 Germany Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 15 Germany Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 16 France Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 17 France Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 18 Italy Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 19 Italy Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 20 Spain Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 21 Spain Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 22 Sweden Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 23 Sweden Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 24 Norway Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 25 Norway Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 26 Denmark Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 30 Asia Pacific Gaucher disease drugs market, by region, 2018 - 2030 (USD Million)
Table 31 China Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 32 China Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 33 Japan Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 34 Japan Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 35 India Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 36 India Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 37 Australia Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 38 Australia Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 39 Thailand Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 40 Thailand Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 41 South Korea Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 42 South Korea Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 43 Latin America Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 44 Latin America Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 45 Latin America Gaucher disease drugs market, by region, 2018 - 2030 (USD Million)
Table 46 Brazil Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 47 Brazil Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 48 Mexico Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 49 Mexico Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 50 Argentina Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 51 Argentina Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 52 Middle East and Africa Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 53 Middle East and Africa Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 54 Middle East and Africa Gaucher disease drugs market, by region, 2018 - 2030 (USD Million)
Table 55 Saudi Arabia Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 57 South Africa Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 58 South Africa Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 59 UAE Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 60 UAE Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)
Table 61 Kuwait Gaucher disease drugs market, by type, 2018 - 2030 (USD Million)
Table 62 Kuwait Gaucher disease drugs market, by therapy, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Gaucher disease drugs: Market outlook
Fig. 9 Gaucher disease drugs: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Gaucher disease drugs market driver impact
Fig. 15 Gaucher disease drugs market restraint impact
Fig. 16 Gaucher disease drugs market strategic initiatives analysis
Fig. 17 Gaucher disease drugs market: Type movement analysis
Fig. 18 Gaucher disease drugs market: Type outlook and key takeaways
Fig. 19 Type 1 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Type 2 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Type 3 market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Gaucher disease drugs market: Therapy movement analysis
Fig. 24 Gaucher disease drugs market: Therapy outlook and key takeaways
Fig. 25 Enzyme replacement therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 26 Substrate replacement therapy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Global gaucher disease drugs market: Regional movement analysis
Fig. 29 Global gaucher disease drugs market: Regional outlook and key takeaways
Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon